Published in BMJ Case Rep on November 19, 2012
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med (2007) 6.97
Advances in H1-antihistamines. N Engl J Med (2004) 3.27
Rhabdomyolysis: a review. Muscle Nerve (2002) 2.89
Chronic insomnia. Lancet (2012) 1.92
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract (2011) 1.61
Contemporary approaches to hyperemesis during pregnancy. Curr Opin Obstet Gynecol (2011) 0.99
Hyponatremia associated with escitalopram. N Engl J Med (2007) 0.98
Syndrome of inappropriate secretion of antidiuretic hormone induced by diclofenac. BMJ (1993) 0.88
Doxylamine toxicity: seizure, rhabdomyolysis and false positive urine drug screen for methadone. BMJ Case Rep (2009) 0.82
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology (2006) 2.12
Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury. Pharmacoepidemiol Drug Saf (2011) 1.45
Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol (2011) 1.40
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics (2012) 1.21
Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. Drug Saf (2010) 1.10
Drug-induced liver injury: insights from genetic studies. Pharmacogenomics (2009) 1.10
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology (2004) 1.09
Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf (2004) 1.07
Pharmacogenomics in drug induced liver injury. Curr Drug Metab (2009) 1.06
Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol (2008) 1.04
Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity. Eur J Gastroenterol Hepatol (2002) 1.02
Mechanisms of drug-induced liver injury. Curr Opin Allergy Clin Immunol (2014) 0.95
Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology. Front Pharmacol (2012) 0.93
Vascular ophthalmological side effects associated with antiviral therapy for chronic hepatitis C are related to vascular endothelial growth factor levels. Antivir Ther (2006) 0.88
HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One (2013) 0.87
Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry (2002) 0.84
Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury. Liver Int (2013) 0.84
Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity? Ann Pharmacother (2004) 0.84
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle. Front Genet (2012) 0.81
Hepatotoxicity related to citalopram. Am J Psychiatry (2004) 0.81
Reflections on running training workshops for research ethics committee members in Spain between 2001 and 2008. Croat Med J (2010) 0.78
Epstein-Barr virus acute cholecystitis. BMJ Case Rep (2012) 0.77
Lansoprazole-induced hepatic dysfunction. Ann Pharmacother (2003) 0.76
Genetic and molecular factors in drug-induced liver injury: a review. Curr Drug Saf (2007) 0.76
Cholestatic hepatitis associated with repaglinide. Diabetes Care (2005) 0.76
Accidental finger ischaemia induced by epinephrine autoinjector. BMJ Case Rep (2013) 0.76
Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol (2008) 0.76
Drug-induced hepatotoxicity. N Engl J Med (2003) 0.76
Indacaterol-induced severe constipation and abdominal pain: is there a role for colonic β3-adrenoceptors? BMJ Case Rep (2013) 0.75
Necrotising soft-tissue infection. BMJ Case Rep (2012) 0.75
A misplaced window. BMJ Case Rep (2012) 0.75
Pulmonary arterial hypertension associated with neurofibromatosis type 1. BMJ Case Rep (2010) 0.75
Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs? World J Gastroenterol (2006) 0.75
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort. PLoS One (2015) 0.75
Mycobacterium tuberculosis: sometimes, a hidden culprit. BMJ Case Rep (2011) 0.75
Symptomatic Bochdalek hernia in an adult patient. BMJ Case Rep (2010) 0.75
Gallstone ileus. BMJ Case Rep (2012) 0.75
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles. Pharmacogenet Genomics (2016) 0.75
Drugs prescription in patients with chronic liver disease: rules for adjusting doses and beyond. Rev Esp Enferm Dig (2012) 0.75